As per MRFR Analysis, the Bone and Joint Health Ingredient Market was valued at USD 18.4 billion in 2023 and is projected to grow from USD 19.81 billion in 2024 to USD 33.3 billion by 2032, with a CAGR of 6.70% during the forecast period. Key drivers include the rising incidence of lifestyle diseases and an aging population, leading to increased reliance on supplements. The vitamins segment dominated the market in 2022, accounting for over 30.0% share, driven by the popularity of healthy lifestyles and the use of vitamin D supplements. North America held the largest market share in 2022, driven by a significant elderly population and high joint pain prevalence.
The market is witnessing significant trends driven by health awareness and product innovation.
Key players include DSM (Netherlands), BASF SE (Germany), Archer-Daniels-Midland Company (US), Glanbia PLC (Ireland), Lonza Group (Switzerland), Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Collech (Australia), Bioiberica S.A.U. (Spain).
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
 populations are aging, which increases the likelihood of developing bone and joint problems. Musculoskeletal problems are the leading cause of morbidity worldwide, leading to a heavy reliance on supplements and other therapeutic techniques. Calcium, vitamin D, and vitamin C are commonly consumed to reduce the likelihood of developing bone and health problems. Vitamin D is required for the growth of strong, healthy bones and teeth.
According to the CDC, arthritis will affect 24% of all adults in the United States in 2021, or 58.5 million people. It is one of the most common reasons for being unable to work. Furthermore, the American Orthopaedic Association 2020 states that Vitamin D is required for the creation, maintenance, and operation of the musculoskeletal system. Adequate vitamin D levels have been associated to increased bone mineral density, less osteoporotic fractures, and improved neuromuscular function. Vitamin D deficiency is becoming more common in the United States, even among persons who have never been labelled as "at-risk." Vitamin D deficiency is becoming more common not only in patients with known risk factors, such as African American or Mexican-American ancestry, obesity, or diabetes, but also in younger people and those with no cancer history. As a result, the increased prevalence of disorders caused by vitamin insufficiency is propelling the market CAGR for bone and joint health ingredients.
According to the WHO, osteoarthritis affects more than 40 million individuals in Europe. As a result, the growing prevalence of orthopedic illnesses around the world is predicted to drive the revenue of the bone and joint health ingredient market.
The bone and joint health ingredient market segmentation, based on type includes calcium, collagen, glucosamine, chondroitin, magnesium, vitamins. The vitamins segment dominated the market in 2022 with a share of over 30.0%. This can be due to the rising popularity of healthy lifestyles, rising life expectancy, and increased emphasis on active living. In addition, rising use of vitamin D supplements to minimize the incidence of bone fracture is driving market expansion. Furthermore, vitamin K has been connected to bone density and has been found to be useful for bone health. People with osteoporosis drink it to minimize their risk of fracture, which is projected to drive the segment throughout the forecast period.
Figure1: Bone and Joint Health Ingredient Market, by Type, 2022 & 2032 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The bone and joint health ingredient market segmentation, based on application, includes nutraceuticals & dietary supplements, food and beverages, pharmaceuticals. Food and beverages are likely to dominate the market over the forecast period, owing to the growing trend of functional food and beverage to support customers' active lifestyles. The functional food and beverages segment of the market analyzed was valued at US$ 699.58 million in 2022 and is expected to reach US$ 1088.56 million by 2032, growing at a 7.61% CAGR between 2022 and 2032.
Bone and Joint Health Ingredient Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. In 2022, North America had the highest revenue share of more than 35.0%. The region's market is being driven by factors such as an increasing elderly population and an increase in the number of people suffering from joint pain. According to the CDC, almost 14.6 million Americans have significant joint pain.
Further, the major countries studiedin the market reportare The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure2: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe bone and joint health ingredient market accounts for the second-largest market share due to a higher number of patients suffering from bone and joint-related disorders, the availability of products in the region. Further, the German bone and joint health ingredient market held the largest market share, and the UK bone and joint health ingredient market was the fastest-growing market in the European region.
The Asia-Pacific Bone and Joint Health Ingredient Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to rising knowledge regarding health and well-being paired with nutritional deficits. Moreover, China’s bone and joint health ingredient market held the largest market share, and the Indian bone and joint health ingredient market was the fastest-growing market in the Asia-Pacific region.
Leading market players are extensively spending in R&D to increase their product lines, which will help the bone and joint health ingredient market grow even more. Market participants are also engaging in a number of strategic initiatives to grow their worldwide presence, with significant market developments including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the bone and joint health ingredient industry must provide cost-effective products.
Manufacturing locally to reduce operational costs is one of the primary business strategies utilized by manufacturers in the worldwide bone and joint health ingredient industry to serve clients and expand the market sector. In recent years, the bone and joint health ingredient industry has provided some of the most significant benefits to medicine. Major players in the bone and joint health ingredient market, such as Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Collech (Australia), Bioiberica S.A.U. (Spain), and others, are attempting to increase market demand by investing in research and development operations.
The Archer-Daniels-Midland Company, or ADM, is an American food processing and commodities trading firm headquartered in Chicago, Illinois, founded in 1902. The company has over 270 plants and 420 crop procurement facilities around the world where cereal grains and oilseeds are processed into products utilized in the food, beverage, nutraceutical, industrial, and animal feed markets. ADM was placed No. 38 on the 2022 Fortune 500 list of the largest firms in the United States. In addition, the organization offers agricultural storage and shipping services. ADM's companies include American River Transportation Company and ADM Trucking, Inc. With its multiple scandals, ADM has garnered enormous media attention and infamy throughout the years, one of which inspired a novel and later film. In October 2020, following regulatory approval, Archer Daniels Midland Company founded PlantPlus Foods, a joint venture between Marfrig and ADM. PlantPlus Foods will provide a full range of finished plant-based food products throughout North and South America, backed by unequalled technology, size, and experience.
Kerry Group plc is an Irish food corporation that is publicly traded. It is traded on the ISEQ in Dublin and the LSE in London. Listowel's Kerry's Main Factory Given the company's origins in the cooperative movement, farmer-suppliers retain a large stake in the business. As of 2022, Kerry Co-operative Creameries is the company's largest single stakeholder. Kerry was created in 1972 as a private corporation (North Kerry Milk Products) in Listowel, County Kerry, with three shareholders: the state-owned Dairy Disposal corporation (42.5%), a federation of eight small farmer co-operatives in Kerry (42.5%), and Erie Casein Company Inc. from the United States (15%). In April 2022, The Kerry group announced its BC-30 or Bacillus Coagulans GBI030, 6086 inventions. The former was previously only available in powder form; however, with innovation in liquid form- the product reach for functional and healthy beverages may be touched, consequently displaying a huge boost for the healthy ingredient industry. Approximately 25 research for the same have now been supported by approximately 25 digestive health benefits, immune health upliftment, and others.
in 2023, The role that collagen can play has gained attention as an increasing number of younger, active consumers take a proactive approach to their mobility and joint health.This has led to further product development in this area. In fact, between 2019 and 2020, there was a 30% increase in the number of new collagen-based joint health product launches.
In 2022, Jollywell, a high-end online nutraceutical company renowned for its nutritional supplements that extend life, introduced a new line of goods that promote longer-term health. The pure, plant-based, non-GMO supplements are safer for the body because they are scientifically prepared with nature's best superfoods.
The all-natural dog treat manufacturer Natural Farm introduced three new product lines in 2023: the dual-texture Natbones Treats, the daily Dental Treats, and the nutrient-dense and sustainably sourced Oceanic Chews, which are currently on the market. With a soft superfood on the inside and a chewy protein on the outside, Natbones Treats have two distinct textures.
The 'evergreen' need for body fat reduction, immunological support, as well as increased interest in joint and bone health supplements, is one of the main reasons why the nutraceutical market in South Korea is booming in 2023, despite inflationary pressures and an economic recession.
On July 20, 2022, Infinitus, a well-known supplier of premium Chinese herbal health products and services, introduced a new line of Li Mai Jian supplements. The same night online, a new product launch with the subject Making Bones Stronger for Joint Health got more than 130,000 views.
In 2022, A sufficient and well-balanced diet and regular exercise are frequently regarded as the cornerstones of good health. As a result, during flu season or other times of illness, people frequently search for specialist foods or vitamin supplements that are believed to boost immunity. However, the composition of our immune system cannot be considerably influenced by any specific diet or vitamin.
Key Companies in the bone and joint health ingredient market include
In April 2022, At "Vita-Foods," Bioberica announced the debut of a new ingredient and products. The former company is a pioneer in life sciences, and their announcement would introduce two near-health-area foods covered digestive health upliftment and skin and beauty enhancement. A variety of functional components for culinary applications will also be offered, including one that will aid in the improvement of type II collagen ingredient joint health.
In May 2022, FutureCeuticals, Inc. has announced that FruiteX-B® is now commercially available in the European Union (EU) through the company's EU distributor, vaneeghen. FruiteX-B is a proprietary, vegan calcium fructoborate mineral complex that is identical to the same chemical found in nature in some fruits, vegetables, nuts, and legumes.
In March 2019, Rousselot introduced hydrolyzed collagen to promote joint health. It promotes healthy cartilage, allows for smooth joint mobility, and reduces the effects of inflammation.
| Attribute/Metric | Details |
| Market Size 2023 | USD 18.4 billion |
| Market Size 2024 | USD 19.81 billion |
| Market Size 2032 | USD 33.3 billion |
| Compound Annual Growth Rate (CAGR) | 6.70% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Â DSM (Netherlands), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), Glanbia PLC (Ireland), Lonza Group (Switzerland), Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Collech (Australia), Bioiberica S.A.U. (Spain). |
| Key Market Opportunities | ·        Consumer awareness about micronutrient deficiencies. |
| Key Market Dynamics | ·        Aging population to drive the market growth. |
Bone Joint Health Ingredients Market Highlights:
Frequently Asked Questions (FAQ) :
The bone and joint health ingredient market size was valued at USD 18.4 Billion in 2023.
The market is projected to grow at a CAGR of 6.70% during the forecast period, 2024-2032.
North America had the largest share of the market.
The key players in the market are Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Collech (Australia), Bioiberica S.A.U. (Spain).
The vitamins bone and joint health ingredient category dominated the market in 2023.
Food and beverage had the largest share of the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level II I have a degree in engineering (civil), with masters in business administration (marketing). with more than 4 years of experience in market research and consulting, i am involved in end-to-end process of market research, proposals, project kickoffs and delivery. i have research knowledge and expertise in consumer goods/packaging domain. also i have worked for various other domains like construction & equipment. effectively managed and delivered more than 60 report studies for regional as well as global clientele.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
